Lotus Eye Hospital Adjusts Evaluation Amidst Mixed Financial Performance Indicators
Lotus Eye Hospital & Institute has recently experienced a change in evaluation, reflecting its market position and financial metrics. The company, known for its conservative financial strategy, has faced challenges over the past year, underperforming compared to the broader market while exhibiting some positive technical trends.
Lotus Eye Hospital & Institute has recently undergone an adjustment in evaluation, reflecting a nuanced view of its market position and financial metrics. The company operates within the Hospital & Healthcare Services sector and has been noted for its conservative financial strategy, particularly highlighted by its low Debt to Equity ratio, which stands at 0 times. This suggests a cautious approach to leveraging its capital.In terms of performance indicators, the stock has been positioned in a mildly bullish range, with technical trends showing some positive movement. The Moving Average Convergence Divergence (MACD) indicator has also indicated bullish signals, suggesting a potential shift in market sentiment.
However, the company's return on equity (ROE) is reported at 2.3, alongside a price-to-book value of 2.4, which may imply a high valuation relative to its earnings. Over the past year, the stock has faced challenges, underperforming compared to the broader market with a return of -18.36%, while profits have seen a significant decline of 65%. This performance stands in contrast to the BSE 500 index, which has recorded returns of 10.63% during the same timeframe.
For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
